126 related articles for article (PubMed ID: 24281352)
1. Galectin-3 coats the membrane of breast cells and makes a signature of tumours.
Simone G; Malara N; Trunzo V; Renne M; Perozziello G; Di Fabrizio E; Manz A
Mol Biosyst; 2014 Feb; 10(2):258-65. PubMed ID: 24281352
[TBL] [Abstract][Full Text] [Related]
2. Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer.
Moiseeva EV; Rapoport EM; Bovin NV; Miroshnikov AI; Chaadaeva AV; Krasilshschikova MS; Bojenko VK; Bijleveld C; van Dijk JE; Den Otter W
Breast Cancer Res Treat; 2005 Jun; 91(3):227-41. PubMed ID: 15952056
[TBL] [Abstract][Full Text] [Related]
3. Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells.
Glinsky VV; Huflejt ME; Glinsky GV; Deutscher SL; Quinn TP
Cancer Res; 2000 May; 60(10):2584-8. PubMed ID: 10825125
[TBL] [Abstract][Full Text] [Related]
4. Galectin-9, a novel prognostic factor with antimetastatic potential in breast cancer.
Yamauchi A; Kontani K; Kihara M; Nishi N; Yokomise H; Hirashima M
Breast J; 2006; 12(5 Suppl 2):S196-200. PubMed ID: 16959001
[TBL] [Abstract][Full Text] [Related]
5. Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer.
Irie A; Yamauchi A; Kontani K; Kihara M; Liu D; Shirato Y; Seki M; Nishi N; Nakamura T; Yokomise H; Hirashima M
Clin Cancer Res; 2005 Apr; 11(8):2962-8. PubMed ID: 15837748
[TBL] [Abstract][Full Text] [Related]
6. Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3.
Bresalier RS; Byrd JC; Wang L; Raz A
Cancer Res; 1996 Oct; 56(19):4354-7. PubMed ID: 8813123
[TBL] [Abstract][Full Text] [Related]
7. Sialylation regulates galectin-3/ligand interplay during mammary tumour progression--a case of targeted uncloaking.
de Oliveira JT; de Matos AJ; Santos AL; Pinto R; Gomes J; Hespanhol V; Chammas R; Manninen A; Bernardes ES; Albuquerque Reis C; Rutteman G; Gärtner F
Int J Dev Biol; 2011; 55(7-9):823-34. PubMed ID: 22161838
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of galectin-3 is associated with progression of human breast cancer.
Castronovo V; Van Den Brûle FA; Jackers P; Clausse N; Liu FT; Gillet C; Sobel ME
J Pathol; 1996 May; 179(1):43-8. PubMed ID: 8691344
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated glycoforms of gelatinase B exhibit a decreased level of binding to galectin-3.
Fry SA; Van den Steen PE; Royle L; Wormald MR; Leathem AJ; Opdenakker G; McDonnell JM; Dwek RA; Rudd PM
Biochemistry; 2006 Dec; 45(51):15249-58. PubMed ID: 17176047
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 interacts with membrane lipids and penetrates the lipid bilayer.
Lukyanov P; Furtak V; Ochieng J
Biochem Biophys Res Commun; 2005 Dec; 338(2):1031-6. PubMed ID: 16248982
[TBL] [Abstract][Full Text] [Related]
11. C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer.
Logullo AF; Lopes AB; Nonogaki S; Soares FA; Netto MM; Nishimoto IN; Brentani MM
Oncol Rep; 2007 Jul; 18(1):121-6. PubMed ID: 17549356
[TBL] [Abstract][Full Text] [Related]
12. Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3.
Bresalier RS; Mazurek N; Sternberg LR; Byrd JC; Yunker CK; Nangia-Makker P; Raz A
Gastroenterology; 1998 Aug; 115(2):287-96. PubMed ID: 9679034
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of galectin-3 in canine mammary tumours.
Choi YK; Hong SH; Kim BH; Kim HC; Woo HJ; Kim DY
J Comp Pathol; 2004; 131(2-3):242-5. PubMed ID: 15276865
[TBL] [Abstract][Full Text] [Related]
14. Truncated galectin-3 inhibits tumor growth and metastasis in orthotopic nude mouse model of human breast cancer.
John CM; Leffler H; Kahl-Knutsson B; Svensson I; Jarvis GA
Clin Cancer Res; 2003 Jun; 9(6):2374-83. PubMed ID: 12796408
[TBL] [Abstract][Full Text] [Related]
15. Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion.
Zou J; Glinsky VV; Landon LA; Matthews L; Deutscher SL
Carcinogenesis; 2005 Feb; 26(2):309-18. PubMed ID: 15528216
[TBL] [Abstract][Full Text] [Related]
16. Effects of the carbohydrate-binding protein galectin-3 on the invasiveness of human breast carcinoma cells.
Le Marer N; Hughes RC
J Cell Physiol; 1996 Jul; 168(1):51-8. PubMed ID: 8647922
[TBL] [Abstract][Full Text] [Related]
17. Cell surface interaction of annexin A2 and galectin-3 modulates epidermal growth factor receptor signaling in Her-2 negative breast cancer cells.
Shetty P; Bargale A; Patil BR; Mohan R; Dinesh US; Vishwanatha JK; Gai PB; Patil VS; Amsavardani TS
Mol Cell Biochem; 2016 Jan; 411(1-2):221-33. PubMed ID: 26438086
[TBL] [Abstract][Full Text] [Related]
18. Binding of galectin-1 to breast cancer cells MCF7 induces apoptosis and inhibition of proliferation in vitro in a 2D- and 3D- cell culture model.
Geiger P; Mayer B; Wiest I; Schulze S; Jeschke U; Weissenbacher T
BMC Cancer; 2016 Nov; 16(1):870. PubMed ID: 27825375
[TBL] [Abstract][Full Text] [Related]
19. On the role of galectin-3 in cancer apoptosis.
Nakahara S; Oka N; Raz A
Apoptosis; 2005 Mar; 10(2):267-75. PubMed ID: 15843888
[TBL] [Abstract][Full Text] [Related]
20. Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model.
Stannard KA; Collins PM; Ito K; Sullivan EM; Scott SA; Gabutero E; Darren Grice I; Low P; Nilsson UJ; Leffler H; Blanchard H; Ralph SJ
Cancer Lett; 2010 Dec; 299(2):95-110. PubMed ID: 20826047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]